Checkvacc Clinical Trial - now listed at City of Hope, page-67

A good question, Target.

No idea. It was the first thing I checked when I saw it go up on the CoH website. Soon would be good. It would be interesting to see a bit more detail on the trial protocol.

Biotech sure does take as much patience as it does patients. However, with so many projects now on the go the pace of news at Imugene is definitely speeding up.

I find it very interesting that LC has not done any interviews after the Announcement of the new Her-vaxx clinical trials. The big outstanding questions in my mind are:

1. The name of the organisation involved in the announced "Investigator Sponsored Study"
2. The identity of the three new "cornerstone investors" who came on board at the recent big CR - (the Annual Report will tell us eventually, so why not tell us now?)
3. Further detail on the partnership with Celularity - especially the timeline for pre-clinical studies of OnCARlytics with CyCART-19.

Possibly there is a link between 1 and 2 above. IMU has not been big on "mystery" in the past so this does have me wondering at the recent apparent media shyness, which is out of character with past behaviour. One possible interpretation is that some very sensitive negotiations are happening in the background. I'm even wondering if LC is actually out of the country at present. Pure speculation on my part.

Anyway - let's all hope for a happy week.

Cheers

Dave